Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.

MLA

Ng, Deanna Wan Jie, et al. “Tumor Biology Remains the Main Determinant of Prognosis in Retroperitoneal Sarcomas: A 14-Year Single-Center Experience.” Asia-Pacific Journal of Clinical Oncology, vol. 13, no. 5, Oct. 2017, pp. e458–65. EBSCOhost, https://doi.org/10.1111/ajco.12662.

APA

Ng, D. W. J., Tan, G. H. C., Chia, C. S., Chee, S. K., Quek, R., Farid, M., & Teo, M. C. C. (2017). Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience. Asia-Pacific Journal of Clinical Oncology, 13(5), e458–e465. https://doi.org/10.1111/ajco.12662

Chicago

Ng, Deanna Wan Jie, Grace Hwei Ching Tan, Claramae Shulyn Chia, Soo Khee Chee, Richard Quek, Mohamad Farid, and Melissa Ching Ching Teo. 2017. “Tumor Biology Remains the Main Determinant of Prognosis in Retroperitoneal Sarcomas: A 14-Year Single-Center Experience.” Asia-Pacific Journal of Clinical Oncology 13 (5): e458–65. doi:10.1111/ajco.12662.